Additionally, ABCC2‐high PRCCs had higher PD‐L1 IHC positivity (combined positive score ≥ 1, p = 0.035; tumor proportion score ≥ 1%, p = 0.006) and immune predictive signature score (p = 0.029). The gene discussed is ABCC2; the disease is neoplasm.